page header

Contents  ·  Introduction  ·  Learning  Objectives  ·  Textbook  ·  Lectures  ·  Procedures  ·  Final Exam  ·  Library  ·  Laboratory  ·  Pharmacy  ·  Imaging  ·  Forms  ·  Videos  ·  About  ·  Contact Us>

Midazolam (Versed)

Category:

  • General anesthetic

Description:

  • Benzodiazepine sedative

Indications:

  • Preoperative sedation (IM)

  • General anesthesia induction, sedation for diagnostic endoscopic procedures, intubation (IV)

Contraindications:

  • Shock, coma, alcohol intoxication

  • Acute narrow-angle glaucoma

Precautions:

  • Pregnancy category D

  • COPD, CHF, chronic renal failure, hepatic disease, elderly

  • Debilitated, myasthenia gravis, other muscular dystrophies and myotonias

Adverse Reactions (Side Effects):

  • CNS: anxiety, confusion, euphoria, headache, insomnia, paresthesia, retrograde amnesia, slurred speech, tremors, weakness

  • CV: bigeminy, hypotension, nodal rhythm, PVCs, tachycardia

  • EENT: blocked ears, blurred vision, diplopia, loss of balance, nystagmus

  • GI: hiccups, increased salivation, nausea, vomiting

  • RESP: apnea, bronchospasm, coughing, dyspnea, laryngospasm, respiratory depression

  • SKIN: pain, pruritis, rash, swelling at injection site, urticaria

Dosage:

Administered intravenously, intramuscularly

  • Adult:            

    • Preoperative sedation: 

      • IM 70-80 mcg/kg 30-60 minutes before general anesthesia

    • Conscious sedation: 

      • IV using 1 mg/ml dilution, titrate slowly to desired effect; give no more than 2.5mg over at least 2 minutes; wait at least 2 minutes to fully evaluate effect; administer small doses to appropriate level of sedation as needed

    • Induction of general anesthesia: 

      • IV 150-350 mcg/kg over 30 seconds, wait 2 minutes follow with 25% of initial dose if needed; use lower doses for patients who are > 55 years age, premedicated, debilitated, or severe systemic disease

  • Child:            

    • Preoperative sedation: 

      • IM 80-200 mcg/kg

    • General anesthesia: 

      • IV 50-200 mcg/kg

 

 

 


The information contained here is an abbreviated summary. For more detailed and complete information, consult the manufacturer's product information sheets or standard textbooks

Source: Operational Medicine 2001,  Health Care in Military Settings, NAVMED P-5139, May 1, 2001, Bureau of Medicine and Surgery, Department of the Navy, 2300 E Street NW, Washington, D.C., 20372-5300

This information is provided by The Brookside Associates.  The Brookside Associates, LLC. is a private organization, not affiliated with any governmental agency. The opinions presented here are those of the author and do not necessarily represent the opinions of the Brookside Associates or the Department of Defense. The presence of any advertising on these pages does not constitute an endorsement of that product or service by either the US Department of Defense or the Brookside Associates. All material presented here is unclassified.

C. 2009, 2014, All Rights Reserved

brookside associates logo

 

 

 

 

 

 

Advertise on this site